For years, investors questioned whether Medtronic was moving quickly and innovating enough. Now, the company is answering with its checkbook. So far in 2026, the Minnesota-run medical device maker has ...

Medtronic (MDT) ended the recent trading session at $83.87, demonstrating a +1.8% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.

Medtronic stock is a "Buy" given its premium-margin medtech, diversification, accelerated growth, and undervalued shares.

Medtronic (MDT) stock rises amid hopes for permanent Category I codes for renal denervation that can widen coverage for the ...

Medtronic gains attention as renal denervation optimism, revenue growth, cardiac care, and diabetes technology reshape its ...

Investors who buy Medtronic now could realize big gains if Biegelsen's prediction comes true. If he's wrong and the stock tanks this year, a legendary dividend program gives shareholders a great ...

If you are wondering whether Medtronic stock is offering good value at its recent price, this article focuses squarely on what the current share price implies about the company. Medtronic recently ...

Medtronic issued a voluntary global recall of its Octopus 4 Tissue Stabilizer after identifying an assembly issue during ...

Medtronic has begun to notify people who may have been affected by a cyberattack that was disclosed more than two months ago.

Company that also makes insulin pumps and other devices tells users what was exposed months after ShinyHunters attack ...

Medtronic's revenue partly depends on the volume of medical procedures performed with its devices. Physicians order more as needed. If a global pandemic sends the number of surgeries in the wrong ...

Healthcare device firm Medtronic is notifying affected customers about a data breach that exposed their personal data to an ...